Tag: caladrius

July 4, 2018

5 Top NASDAQ Pharma Stocks of Q2 2018

About half way through 2018 finishing the second quarter, the INN takes a look at the 5 top pharma stocks...
March 23, 2018

Caladrius Biosciences Reports 2017 Fourth Quarter and Year End Financial Results

Caladrius Biosciences (Nasdaq:CLBS) a development-stage biopharmaceutical company with multiple technology platforms targeting autoimmune and select cardiovascular indications, announces financial results...
January 18, 2018

Caladrius Biosciences Announces Completion of Enrollment of Phase 2 T-Rex Clinical Trial of CLBS03 for Type 1 Diabetes

Caladrius Biosciences (NASDAQ:CLBS) a development-stage biopharmaceutical company with multiple technology platforms targeting autoimmune and select cardiology indications, announces the completion of...